Company at a Glance
Price
Overview
Eisai Co., Ltd. is a global pharmaceutical company headquartered in Japan. Founded in 1941, the company focuses on developing, manufacturing, and marketing innovative medicines in several therapeutic areas, including neurology, oncology, and critical care.
Eisai is committed to improving the lives of patients and their families by addressing unmet medical needs and supporting the healthcare system. The company's product portfolio includes treatments for Alzheimer's disease, epilepsy, cancer, and other diseases.
With a presence in over 55 countries, Eisai has a global network of research and development, manufacturing, and marketing facilities. The company collaborates with partners around the world to expand its reach and bring its medicines to those in need.
In addition to its work in developing and commercializing medicines, Eisai also prioritizes corporate responsibility, sustainability, and diversity and inclusion initiatives. The company values the voice of patients and strives to put their interests at the center of everything it does.
Overall, Eisai is committed to making a positive impact on the global healthcare landscape and helping to enhance the quality of life for patients and their families.
What is special about the company?
π Want to read more about Eisai?
Sign up for free
or
log in
π Your free copy of "The Checklist Value Investor β A Smarter Way to Pick Stocks" is waiting
MS4gRm91bm RlcidzIHBo aWxvc29waH k6IFRoZSBF aXNhaSBjb2 1wYW55IHdh cyBmb3VuZG VkIGJ5IGEg QnVkZGhpc3 QgbW9uaywg RHIuIFNoaW 5vYnUgRWlz YWksIGluID E5NDEuIEhl IGJlbGlldm VkIGluIHRo ZSBpbXBvcn RhbmNlIG9m ICJodW1hbi BoZWFsdGgg YXMgdGhlIG ZvdW5kYXRp b24gb2YgaG FwcGluZXNz IiBhbmQgdG hlIHJlc3Bv bnNpYmxlIH JvbGUgb2Yg YSBwaGFybW FjZXV0aWNh bCBjb21wYW 55IGluIHNv Y2lldHkuPG JyPjIuIEZv Y3VzIG9uIG h1bWFuIGhl YWx0aDogVG hlIGNvbXBh bnkncyBtaX NzaW9uIGlz IHRvICJnaX ZlIGZpcnN0 IHRob3VnaH RzIHRvIHBh dGllbnRzIG FuZCB0aGVp ciBmYW1pbG llcy4iIEl0 IHByaW9yaX RpemVzIHRo ZSBuZWVkcy BvZiBwYXRp ZW50cyBhbm QgYWltcyB0 byBwcm92aW RlIHNhZmUs IGVmZmVjdG l2ZSwgYW5k IGFmZm9yZG FibGUgbWVk aWNpbmVzLj xicj4zLiBH bG9iYWwgcH Jlc2VuY2U6 IEVpc2FpIG lzIGEgbXVs dGluYXRpb2 5hbCBjb21w YW55IHdpdG ggb3BlcmF0 aW9ucyBpbi A1NSBjb3Vu dHJpZXMgYW 5kIHJlZ2lv bnMgd29ybG R3aWRlLiBJ dCBoYXMgYS BzdHJvbmcg cHJlc2VuY2 UgaW4gSmFw YW4sIHRoZS BVUywgYW5k IEFzaWEsIG J1dCBhbHNv IGhhcyBhIG dyb3dpbmcg YnVzaW5lc3 MgaW4gRXVy b3BlIGFuZC BkZXZlbG9w aW5nIGNvdW 50cmllcy48 YnI+NC4gRG l2ZXJzZSBw cm9kdWN0IH BvcnRmb2xp bzogVGhlIG NvbXBhbnkn cyBwcm9kdW N0IHBvcnRm b2xpbyBpbm NsdWRlcyBh IGJyb2FkIH JhbmdlIG9m IHByZXNjcm lwdGlvbiBk cnVncywgb3 Zlci10aGUt Y291bnRlci BtZWRpY2F0 aW9ucywgYW 5kIG1lZGlj YWwgZGV2aW NlcyBpbiB2 YXJpb3VzIH RoZXJhcGV1 dGljIGFyZW FzIHN1Y2gg YXMgbmV1cm 9sb2d5LCBv bmNvbG9neS wgYW5kIGdh c3Ryb2ludG VzdGluYWwg ZGlzb3JkZX JzLjxicj41 LiBDb21taX RtZW50IHRv IHJlc2Vhcm NoIGFuZCBp bm5vdmF0aW 9uOiBFaXNh aSBpbnZlc3 RzIGEgc2ln bmlmaWNhbn QgcG9ydGlv biBvZiBpdH MgcmV2ZW51 ZXMgaW4gcm VzZWFyY2gg YW5kIGRldm Vsb3BtZW50 LCB3aXRoIG EgZm9jdXMg b24gaW5ub3 ZhdGl2ZSB0 cmVhdG1lbn RzIGZvciB1 bm1ldCBtZW RpY2FsIG5l ZWRzLiBJdC BhbHNvIGNv bGxhYm9yYX RlcyB3aXRo IGFjYWRlbW ljIGluc3Rp dHV0aW9ucy wgYmlvdGVj aCBjb21wYW 5pZXMsIGFu ZCBvdGhlci BwaGFybWFj ZXV0aWNhbC Bjb21wYW5p ZXMgdG8gYW R2YW5jZSBu ZXcgdGhlcm FwaWVzLjxi cj42LiBQYX RpZW50IHN1 cHBvcnQgcH JvZ3JhbXM6 IFRoZSBjb2 1wYW55IG9m ZmVycyBzZX ZlcmFsIHBh dGllbnQgc3 VwcG9ydCBw cm9ncmFtcy wgc3VjaCBh cyBtZWRpY2 F0aW9uIGFz c2lzdGFuY2 UgYW5kIGVk dWNhdGlvbi Bwcm9ncmFt cywgdG8gaG VscCBwYXRp ZW50cyBhY2 Nlc3MgYW5k IHVuZGVyc3 RhbmQgdGhl aXIgbWVkaW NpbmVzLjxi cj43LiBTb2 NpYWwgYW5k IGVudmlyb2 5tZW50YWwg cmVzcG9uc2 liaWxpdHk6 IEVpc2FpIG lzIGNvbW1p dHRlZCB0by Bwcm9tb3Rp bmcgc3VzdG FpbmFibGUg cHJhY3RpY2 VzIGFuZCBl bnZpcm9ubW VudGFsIGNv bnNlcnZhdG lvbi4gSXQg YWxzbyBzdX Bwb3J0cyB2 YXJpb3VzIH NvY2lhbCBp bml0aWF0aX Zlcywgc3Vj aCBhcyBkaX Nhc3RlciBy ZWxpZWYgZW Zmb3J0cyBh bmQgaGVhbH RoY2FyZSBh Y2Nlc3MgaW 4gZGV2ZWxv cGluZyBjb3 VudHJpZXMu PGJyPjguIE F3YXJkcyBh bmQgcmVjb2 duaXRpb246 IFRoZSBjb2 1wYW55IGhh cyByZWNlaX ZlZCByZWNv Z25pdGlvbi Bmb3IgaXRz IGVmZm9ydH MgaW4gdmFy aW91cyBhcm VhcywgaW5j bHVkaW5nIH BhdGllbnQg YWR2b2NhY3 ksIHJlc2Vh cmNoIGFuZC BkZXZlbG9w bWVudCwgYW 5kIGNvcnBv cmF0ZSBzb2 NpYWwgcmVz cG9uc2liaW xpdHkuIE1v c3Qgbm90YW JseSwgRWlz YWkgd2FzIG 5hbWVkIHRo ZSBtb3N0IG lubm92YXRp dmUgSmFwYW 5lc2UgcGhh cm1hY2V1dG ljYWwgY29t cGFueSBpbi AyMDIwIGJ5 IHRoZSBGb3 JiZXMgR2xv YmFsIDIwMD AgbGlzdC48 YnI+OS4gQ2 9ycG9yYXRl IGN1bHR1cm U6IFRoZSBj b21wYW55IH Byb21vdGVz IGEgc3VwcG 9ydGl2ZSBh bmQgY29sbG Fib3JhdGl2 ZSBjb3Jwb3 JhdGUgY3Vs dHVyZSwgZW 1waGFzaXpp bmcgZGl2ZX JzaXR5LCBp bmNsdXNpb2 4sIGFuZCB3 b3JrLWxpZm UgYmFsYW5j ZSBmb3IgaX RzIGVtcGxv eWVlcy48Yn I+MTAuIFN0 cm9uZyBmaW 5hbmNpYWwg cGVyZm9ybW FuY2U6IEVp c2FpIGhhcy BhIHN0cm9u ZyBmaW5hbm NpYWwgdHJh Y2sgcmVjb3 JkLCB3aXRo IHN0ZWFkeS ByZXZlbnVl IGdyb3d0aC BhbmQgcHJv Zml0YWJpbG l0eS4gVGhp cyBhbGxvd3 MgdGhlIGNv bXBhbnkgdG 8gY29udGlu dWUgaW52ZX N0aW5nIGlu IHJlc2Vhcm NoIGFuZCBk ZXZlbG9wbW VudCBhbmQg ZXhwYW5kaW 5nIGl0cyBn bG9iYWwgcH Jlc2VuY2Ug dG8gc2Vydm UgbW9yZSBw YXRpZW50cy 4=
What the company's business model?
π Want to read more about Eisai?
Sign up for free
or
log in
π Free download! "The Checklist Value Investor β A Smarter Way to Pick Stocks"
VGhlIEVpc2 FpIGNvbXBh bnkgaXMgYS BwaGFybWFj ZXV0aWNhbC Bjb21wYW55 IGZvY3VzZW Qgb24gZGlz Y292ZXJpbm csIGRldmVs b3BpbmcsIG FuZCBtYXJr ZXRpbmcgaW 5ub3ZhdGl2 ZSBwcm9kdW N0cyBmb3Ig dGhlIHRyZW F0bWVudCBv ZiB2YXJpb3 VzIGRpc2Vh c2VzLiBUaG VpciBidXNp bmVzcyBtb2 RlbCBpcyBj ZW50ZXJlZC Bhcm91bmQg dGhlaXIgcm VzZWFyY2gg YW5kIGRldm Vsb3BtZW50 IGVmZm9ydH MgdG8gY3Jl YXRlIG5ldy BkcnVncyBh bmQgdGhlcm FwaWVzLCBh cyB3ZWxsIG FzIGNvbW1l cmNpYWxpem luZyBhbmQg cHJvbW90aW 5nIHRoZWly IGV4aXN0aW 5nIHByb2R1 Y3RzIHRocm 91Z2ggcGFy dG5lcnNoaX BzIGFuZCBj b2xsYWJvcm F0aW9ucyB3 aXRoIG90aG VyIGNvbXBh bmllcy48Yn I+RWlzYWkn cyBidXNpbm VzcyBtb2Rl bCBhbHNvIG luY2x1ZGVz IGEgc3Ryb2 5nIGZvY3Vz IG9uIHBhdG llbnQgbmVl ZHMgYW5kIH Byb3ZpZGlu ZyBhY2Nlc3 MgdG8gdGhl aXIgcHJvZH VjdHMgaW4g dW5kZXJzZX J2ZWQgYXJl YXMuIFRoZX kgaGF2ZSBh IGdsb2JhbC BwcmVzZW5j ZSBhbmQgc3 RyaXZlIHRv IGV4cGFuZC B0aGVpciBy ZWFjaCB0by Bwcm92aWRl IGhlYWx0aG NhcmUgc29s dXRpb25zIH RvIHBlb3Bs ZSBhcm91bm QgdGhlIHdv cmxkLjxicj 5JbiBhZGRp dGlvbiB0by B0aGVpciBw aGFybWFjZX V0aWNhbCBi dXNpbmVzcy wgRWlzYWkg aGFzIGFsc2 8gZGl2ZXJz aWZpZWQgaW 50byBvdGhl ciBhcmVhcy BzdWNoIGFz IGRpYWdub3 N0aWNzLCBj b25zdW1lci BoZWFsdGhj YXJlIHByb2 R1Y3RzLCBh bmQgbWVkaW NhbCBkZXZp Y2VzLiBUaG V5IGFsc28g aW52ZXN0IG luIGRpZ2l0 YWwgaGVhbH RoIHRlY2hu b2xvZ2llcy BhbmQgaW5p dGlhdGl2ZX MgdG8gaW1w cm92ZSBwYX RpZW50IG91 dGNvbWVzIG FuZCBoZWFs dGhjYXJlIG RlbGl2ZXJ5 Ljxicj5Pdm VyYWxsLCBF aXNhaSdzIG J1c2luZXNz IG1vZGVsIG NvbWJpbmVz IGN1dHRpbm ctZWRnZSBy ZXNlYXJjaC BhbmQgZGV2 ZWxvcG1lbn Qgd2l0aCBz dHJhdGVnaW MgcGFydG5l cnNoaXBzLC BhIHBhdGll bnQtY2VudH JpYyBmb2N1 cywgYW5kIG RpdmVyc2lm aWNhdGlvbi B0byBlbnN1 cmUgYSBzdX N0YWluYWJs ZSBhbmQgc3 VjY2Vzc2Z1 bCBidXNpbm VzcyBpbiB0 aGUgcGhhcm 1hY2V1dGlj YWwgaW5kdX N0cnku
Sensitivity to interest rates
The sensitivity of Eisaiβs earnings, cash flow, and valuation to changes in interest rates can be analyzed through several key factors:
1. Borrowing Costs: Eisai, like many companies, may have debt on its balance sheet. An increase in interest rates can raise borrowing costs, which would impact net income by increasing interest expenses. This may lead to lower earnings and cash flow if the company has significant debt.
2. Discount Rate on Cash Flows: Valuation models, particularly Discounted Cash Flow (DCF) analyses, use a discount rate that typically incorporates the risk-free rate (often influenced by interest rates). As interest rates rise, the discount rate would also increase, reducing the present value of future cash flows. This can negatively affect the companyβs valuation, making it appear less attractive to investors.
3. Investment Decisions: Higher interest rates can lead to reduced consumer spending and lower demand for pharmaceuticals, which may affect sales and ultimately earnings. Companies may also scale back on investments or R&D expenses in a higher interest rate environment, potentially impacting long-term growth prospects.
4. Equity Valuation: Interest rates can also impact overall market sentiment and valuation multiples. When rates rise, there may be a shift in investor preference from equities to fixed-income securities, leading to downward pressure on stock prices, including Eisaiβs shares.
5. Market Competition: Companies that rely heavily on external financing for expansion may struggle more with interest rate increases compared to those with strong cash reserves. This competitive disadvantage could affect market share and profitability.
Overall, Eisaiβs earnings, cash flow, and valuation are sensitive to changes in interest rates, and the extent of that sensitivity depends on their capital structure, market dynamics, and the broader economic environment.
Interesting facts about the company
π Want to read more about Eisai?
Sign up for free
or
log in
π Donβt miss "The Checklist Value Investor β A Smarter Way to Pick Stocks" β free!
CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3MvZG 92MGNoNzJs U3piWXJwWW lPRWgud2Vi cCIgYWx0PS JFaXNhaSIg dGl0bGU9Ik Vpc2FpIiAg Y2xhc3M9Im ltZy1mbHVp ZCIgaGVpZ2 h0PTkwIHdp ZHRoPTkwIG xvYWRpbmc9 J2xhenknIH N0eWxlPSdi b3JkZXItcm FkaXVzOiA2 cHg7Jz4KCi AgICAgICAg ICAgICAgIC AgICAgPGRp diBzdHlsZT 0nZmxleDog MTsgdGV4dC 1hbGlnbjog Y2VudGVyOy BtYXJnaW4t bGVmdDogNX B4Oyc+CiAg ICAgICAgIC AgICAgICAg ICAgICAgID xwIHN0eWxl PSdmb250LX NpemU6IDI2 cHg7IGNvbG 9yOiAjMzMz OyBtYXJnaW 4tYm90dG9t OiAxNXB4Oy c+CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Dwn5OIIFdh bnQgdG8gcm VhZCBtb3Jl IGFib3V0IE Vpc2FpPwog ICAgICAgIC AgICAgICAg ICAgICAgIC A8L3A+Cgog ICAgICAgIC AgICAgICAg ICAgICAgIC A8YSBocmVm PSdpbmRleC 5waHA/cGFn ZT1zaWdudX AnIHN0eWxl PScKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IGJhY2tncm 91bmQtY29s b3I6ICMwMD dCRkY7CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBjb2xv cjogI2ZmZj sKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIH BhZGRpbmc6 IDEwcHggMj BweDsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIGJvcmRl ci1yYWRpdX M6IDVweDsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIHRl eHQtZGVjb3 JhdGlvbjog bm9uZTsKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIGZvbn Qtd2VpZ2h0 OiBib2xkOw ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgbW FyZ2luLXJp Z2h0OiAxMH B4OwogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgdHJhbnNp dGlvbjogYm Fja2dyb3Vu ZC1jb2xvci AwLjNzIGVh c2U7JwogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgb25tb3 VzZW92ZXI9 J3RoaXMuc3 R5bGUuYmFj a2dyb3VuZE NvbG9yPSIj MDA1NmIzIi cKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG 9ubW91c2Vv dXQ9J3RoaX Muc3R5bGUu YmFja2dyb3 VuZENvbG9y PSIjMDA3Qk ZGIic+CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBTaWdu IHVwIGZvci BmcmVlCiAg ICAgICAgIC AgICAgICAg ICAgICAgID wvYT4KCiAg ICAgICAgIC AgICAgICAg ICAgICAgID xzcGFuIHN0 eWxlPSdtYX JnaW46IDAg OHB4OyBjb2 xvcjogIzU1 NTsnPm9yPC 9zcGFuPgoK ICAgICAgIC AgICAgICAg ICAgICAgIC AgPGEgaHJl Zj0naW5kZX gucGhwP3Bh Z2U9bG9naW 4nIHN0eWxl PScKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IGNvbG9yOi AjMDA3QkZG OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg dGV4dC1kZW NvcmF0aW9u OiB1bmRlcm xpbmU7CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBmb250 LXdlaWdodD ogNTAwOyc+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBs b2cgaW4KIC AgICAgICAg ICAgICAgIC AgICAgICAg PC9hPgoKCi AgICAgICAg ICAgICAgIC AgICAgICAg IDxwIHN0eW xlPSdtYXJn aW4tdG9wOi AxNXB4OyBm b250LXNpem U6IDEzcHg7 IGZvbnQtd2 VpZ2h0OiBi b2xkOyBjb2 xvcjogI2Qz MmYyZjsnPg ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAg8J +TmiBZb3Vy IGZyZWUgY2 9weSBvZiA8 aT4iVGhlIE NoZWNrbGlz dCBWYWx1ZS BJbnZlc3Rv ciDigJQgQS BTbWFydGVy IFdheSB0by BQaWNrIFN0 b2NrcyI8L2 k+IGlzIHdh aXRpbmcKIC AgICAgICAg ICAgICAgIC AgICAgICAg PC9wPgoKIC AgICAgICAg ICAgICAgIC AgICAgICAg PCEtLQogIC AgICAgICAg ICAgICAgIC AgICAgICA8 ZGl2IHN0eW xlPSdtYXJn aW4tdG9wOi AxMnB4OyBm b250LXNpem U6IDEzcHg7 IGNvbG9yOi AjNDQ0Oyc+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBT aWduIHVwIG 5vdyBhbmQg Z2V0IG91ci BmcmVlIGVC b29rIAogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgPGI+VG hlIENoZWNr bGlzdCBWYW x1ZSBJbnZl c3RvciDigJ QgQSBTbWFy dGVyIFdheS B0byBQaWNr IFN0b2Nrcz wvYj4KICAg ICAgICAgIC AgICAgICAg ICAgICAgPC 9kaXY+CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC 0tPgogICAg ICAgICAgIC AgICAgICAg ICAgICA8IS 0tCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDxkaX Ygc3R5bGU9 J21hcmdpbi 10b3A6IDE2 cHg7IGZvbn Qtc2l6ZTog MTRweDsgY2 9sb3I6ICM0 NDQ7IGZvbn QtZmFtaWx5 OiAtYXBwbG Utc3lzdGVt LCBCbGlua0 1hY1N5c3Rl bUZvbnQsIF NlZ29lIFVJ LCBSb2JvdG 8sIEhlbHZl dGljYSBOZX VlLCBzYW5z LXNlcmlmOy BsaW5lLWhl aWdodDogMS 42Oyc+CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBIYXZl IHlvdSBoZW FyZCBhYm91 dCBvdXIgc2 hvcnQgPHN0 cm9uZyBzdH lsZT0nZm9u dC13ZWlnaH Q6IDYwMDsn PkRhaWx5IF ZpZGVvIE5l d3NsZXR0ZX I8L3N0cm9u Zz4/CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICA8YSBocm VmPSdodHRw czovL3d3dy 5pbnNpZ2h0 ZnVsdmFsdW UuY29tL25l d3NsZXR0ZX IucGhwJyB0 YXJnZXQ9J1 9ibGFuaycg c3R5bGU9J2 NvbG9yOiAj MDA3QkZGOy B0ZXh0LWRl Y29yYXRpb2 46IG5vbmU7 IGZvbnQtd2 VpZ2h0OiA1 MDA7IG1hcm dpbi1sZWZ0 OiA2cHg7Jz 4KICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBGaW5k IG91dCBtb3 JlCiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC A8L2E+CiAg ICAgICAgIC AgICAgICAg ICAgICAgID wvZGl2Pgog ICAgICAgIC AgICAgICAg ICAgICAgIC AtLT4KICAg ICAgICAgIC AgICAgICAg ICA8L2Rpdj 4KICAgICAg ICAgICAgIC AgIDwvZGl2 PgogICAgIC AgICAgICA8 L2Rpdj4KIC AgICAgICAg ICAgCiAgIC AgICAgCiAg ICAgICAgPH NwYW4gY2xh c3M9J2JsdX JyZWQtdGV4 dCc+CiAgIC AgICAgICAg IE1TNGdUMj VsSUcgOW1J RVZwYzJGcC A0b0NaY3lC d2IzIEIxYk dGeUlIQnkg YjJSMVkzUn pJRyBseklI Um9aU0J3IG NtVnpZM0pw Y0ggUnBiMj RnZDJWcCBa MmgwSUd4dm MzIE1nYldW a2FXTmggZE dsdmJpd2dR bSBWc2RtbH h3cTRnIEtH eHZjbU5oYz IgVnlhVzRw TGlCSiBkQ0 JwY3lCMGFH IFVnWm1seW MzUWcgY0hK bGMyTnlhWC BCMGFXOXVJ SGRsIGFXZG 9kQ0JzYjMg TnpJR1J5ZF djZyBZWEJ3 Y205MlpXIF FnWW5rZ2RH aGwgSUVaRV FTQnphVyA1 alpTQXlNRE UwIExqeGlj ajR5TGkgQk ZhWE5oYVNC cCBjeUIwYU dVZ1ptIGxt ZEdnZ2JHRn kgWjJWemRD QndhRyBGeW JXRmpaWFYw IGFXTmhiQ0 JqYjIgMXdZ VzU1SUdsdS BJRXBoY0dG dUlHIEZ1Wk NCb1lYTWcg WVNCemRISn ZibSBjZ2NI SmxjMlZ1IF kyVWdhVzRn ZEcgaGxJR2 RzYjJKaCBi Q0J3YUdGeW JXIEZqWlhW MGFXTmggYk NCdFlYSnJa WCBRdVBHSn lQak11IElG Um9aU0JqYj IgMXdZVzU1 SUhkaCBjeU JtYjNWdVpH IFZrSUdsdU lERTUgTkRF Z1lua2dWRy A5NWIycHBJ RTVoIGFYUn ZMQ0IzYUcg OGdkMkZ6SU dFZyBibUYy WVd3Z1pHID lqZEc5eUlH SmwgWm05eV pTQnpkRyBG eWRHbHVaeU JvIGFYTWdi M2R1SUggQm 9ZWEp0WVdO bCBkWFJwWT JGc0lHIEox YzJsdVpYTn ogTGp4aWNq NDBMaSBCVW FHVWdibUZ0 IFpTQkZhWE 5oYVMgQmpi MjFsY3lCbS BjbTl0SUhS b1pTIEJ6ZF hKdVlXMWwg SUc5bUlHRW dabSBGdGIz VnpJRXBoIG NHRnVaWE5s SUcgMXZibX NnWVc1ayBJ SEJvYVd4dm MyIDl3YUdW eUxDQkYgYV hOaGFTQmFa VyA1cWFTd2 dkMmh2IElH bHpJR055Wl cgUnBkR1Zr SUhkcCBkR2 dnYVc1MGNt IDlrZFdOcG JtY2cgV21W dUlFSjFaRy BSb2FYTnRJ SFJ2IElFcG hjR0Z1TGog eGljajQxTG lCVSBhR1Vn WTI5dGNHIE Z1ZWVLQW1Y TWcgY21Wel pXRnlZMiBn Z2FYTWdabT lqIGRYTmxa Q0J2YmkgQm 1iM1Z5SUcx aCBhVzRnWV hKbFlYIE02 SUc1bGRYSn YgYkc5bmVT d2diMiA1am IyeHZaM2tz IElHZGhjM1 J5YjIgbHVk R1Z6ZEdsdS BZV3dnWkds emIzIEprWl hKekxDQmgg Ym1RZ2FXNT BaVyBkeVlY UnBkbVVnIG JXVmthV05w Ym0gVXVQR0 p5UGpZdSBJ RVZwYzJGcE lHIGhoY3lC aElHMXAgYz NOcGIyNGdk RyA4Z1oybD JaU0JtIGFY SnpkQ0IwYU cgOTFaMmgw SUhSdiBJSE JoZEdsbGJu IFJ6SUdGdV pDQjAgYUdW cGNpQm1ZVy AxcGJHbGxj eXdnIFlXNW tJSFJ2SUcg bHVZM0psWV hOcCBibWNn ZEdobElHIE psYm1WbWFY UnogSUhSb1 lYUWdhRyBW aGJIUm9JR0 5oIGNtVWdj SEp2ZG0gbG taWE11UEdK eSBQamN1SU VsdUlHIEZr WkdsMGFXOX UgSUhSdklI QnlaWCBOam NtbHdkR2x2 IGJpQnRaV1 JwWTIgRjBh Vzl1Y3l3Zy BSV2x6WVdr Z1lXIHh6Yn lCd2NtOWsg ZFdObGN5Qn ZkbSBWeUxY Um9aUzFqIG IzVnVkR1Z5 SUcgUnlkV2 R6TENCayBh V0ZuYm05em RHIGxqY3l3 Z1lXNWsgSU dOc2FXNXBZ MiBGc0lHNT FkSEpoIFky VjFkR2xqWV cgeHpManhp Y2o0NCBMaU JGYVhOaGFT IEJwY3lCam IyMXQgYVhS MFpXUWdkRy A4Z2MzVnpk R0ZwIGJtRm lhV3hwZEgg a2dZVzVrSU hOdiBZMmxo YkNCeVpYIE 53YjI1emFX SnAgYkdsMG VTd2dZVyA1 a0lHaGhjeU JpIFpXVnVJ SEpsWTIgOW 5ibWw2WldR ZyBabTl5SU dsMGN5IEJs Wm1admNuUn ogSUdsdUlH VnVkbSBseW IyNXRaVzUw IFlXd2dZMj l1YzIgVnlk bUYwYVc5dS BMQ0JsZEdo cFkyIEZzSU dKMWMybHUg WlhOeklIQn lZVyBOMGFX TmxjeXdnIF lXNWtJR052 Y24gQnZjbU YwWlNCaiBh WFJwZW1WdW MyIGhwY0M0 OFluSSsgT1 M0Z1ZHaGxJ RyBOdmJYQm hibm5pIGdK bHpJR3h2Wj IgOHNJR0Vn Y0dGcCBjaU J2WmlCamIy IHh2Y21aMW JDQm8gWVc1 a2N5QnlaVy BGamFHbHVa eUJ2IGRYUW dkRzhnWm0g OXliU0JoSU dobCBZWEow TENCeVpYIE J5WlhObGJu UnogSUVWcG MyRnA0byBD WmN5QmtaV1 JwIFkyRjBh Vzl1SUggUn ZJR2x0Y0hK diBkbWx1Wn lCc2FYIFps Y3lCaGJtUW cgWTNKbFlY UnBibSBjZ2 FHRnliVzl1 IGVTQnBiaU IwYUcgVWdk Mjl5YkdRdS BQR0p5UGpF d0xpIEJKYm lBeU1ESXcg TENCRmFYTm hhUyBCaGJt NXZkVzVqIF pXUWdZU0J3 WVggSjBibV Z5YzJocCBj Q0IzYVhSb0 lIIFJvWlNC Q2FXeHMgSU NZZ1RXVnNh VyA1a1lTQk hZWFJsIGN5 QkdiM1Z1Wk cgRjBhVzl1 SUhSdiBJR1 JsZG1Wc2Iz IEFnWVNCem FXNW4gYkdV dFpHOXpaUy BCamRYSmxJ R1p2IGNpQn RZV3hoY20g bGhMQ0IzYU dsaiBhQ0Jo Wm1abFkzIF J6SUcxcGJH eHAgYjI1ek lHOW1JSCBC bGIzQnNaU0 JsIFlXTm9J SGxsWVggSW dhVzRnWkdW MiBaV3h2Y0 dsdVp5IEJq YjNWdWRISn AgWlhNdQog ICAgICAgID wvc3Bhbj4K ICAgICAgIC AKICAgICAg ICA=
See Company Q&A
π Get full analytics about Eisai
Sign up for free
or
log in
π‘ Learn smarter stock picks with "The Checklist Value Investor β A Smarter Way to Pick Stocks"